FDA warns consumers of the dangerous side effect of Neptune's Fix

FDA warns consumers of the dangerous side effect of Neptune’s Fix

The Food and Drug Administration (FDA) is warning consumers not to buy or use any Neptune’s Fix products because they may contain tianeptine, a potentially dangerous substance that can cause severe adverse effects, including death.

What is Tianeptine?

Tianeptine is a tricyclic antidepressant that is not FDA-approved in the United States for any medical conditions. However, it is sometimes prescribed in other countries to treat depression. Tianeptine has the potential for abuse, especially among people with opioid use disorder.

Dangers of Tianeptine

Tianeptine can cause a range of serious adverse effects, including:

  • Agitation
  • Drowsiness
  • Confusion
  • Sweating
  • Rapid heartbeat
  • High blood pressure
  • Nausea
  • Vomiting
  • Breathing difficulties
  • Coma
  • Death

What to Do if You Have Used Tianeptine

If you have used tianeptine or any product that may contain tianeptine, please seek medical attention immediately. You can also report any adverse effects to the FDA’s MedWatch Safety Information and Adverse Event Reporting Program.

How to Protect Yourself

To protect yourself from the dangers of tianeptine, please follow these guidelines:

Avoid tianeptine and tianeptine-containing products:

  • Do not purchase or use any products that contain tianeptine. This includes products marketed as dietary supplements, anxiety or depression remedies, or opioid use disorder (OUD) treatments.

Be aware of tianeptine’s aliases:

  • Recognize tianeptine by its various names, including tianeptine sulfate, tianeptine sodium powder, Tianaa, Tianna Green, Tianna Red, and Tianna White. This information can help you identify tianeptine in product labels or ingredient lists.

Report adverse effects to the FDA:

  • If you or someone you know experiences adverse effects after using a tianeptine-containing product, report it to the FDA’s MedWatch Safety Information and Adverse Event Reporting Program. This reporting allows the FDA to track the extent of tianeptine-related harm and take appropriate action.

Seek medical attention promptly:

  • If you believe you have consumed tianeptine or a tianeptine-containing product, seek medical attention immediately. This is crucial for addressing any potential health complications and receiving appropriate medical care.

Educate others about tianeptine’s risks:

  • Share information about the dangers of tianeptine with your friends, family, and community members. Increasing awareness can help prevent others from falling victim to tianeptine-related harm.

Support ongoing research and regulatory efforts:

  • Stay informed about ongoing research on tianeptine’s effects and potential therapeutic applications. Additionally, support efforts to regulate tianeptine and prevent its unauthorized sale or distribution.

By following these protective measures, you can reduce your risk of exposure to tianeptine and its associated harm. Remember, staying informed and taking proactive steps is essential for safeguarding your health and well-being.

We offer the most up-to-date information from top experts, new research, and health agencies, but our content is not meant to be a substitute for professional guidance. When it comes to the medication you're taking or any other health questions you have, always consult your healthcare provider directly.
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Are COVID-19 Vaccines Safe For Patients Suffering From Rheumatic Arthritis And Lupus Disease?

Suffering from Rheumatic Arthritis and worried if you should get vaccinated against…

Tips to enjoy stress-free periods

Everyone experiences stress at some point of time and it can lead…

Here’s How Much They Will Cost Now

 Here’s How Much They Will Cost Now. Amid a sharp fall in…

Ontario reports record number of new COVID-19 cases with more than 16,700 infections

There are 205 people in intensive care due to COVID-19, which is an increase of five compared with Thursday.